Cancer Screening Test

The most important factor for the successful treatment of all cancers is the early detection of the cancer cells in the body. In most situations cancer is not detected until it reaches more advanced stages. Clinical diagnostic methods, including radiological imaging, are very expensive, inconvenient and perhaps not sensitive enough to detect very small tumors or group of cancer cells. In majority of cases, diagnostic tests are conducted in response to a physical symptom in patients. In other words, we are mostly not aware of the presence of cancer cells in the body until we notice a physical abnormality.

ONCOLAB in Boston, MA offers a very sensitive diagnostic test called AMAS which measures the serum levels of AMA (Anti-Malignin Antibody), an antibody found to be elevated in most patients with a wide range of active non-terminal malignancies. For sera determined within 24 hours of being drawn, the false-positive and false-negative rates are less than 1%. In some cases, the AMAS test has been positive (elevated) 1 to 19 months before clinical detection. AMAS test measures levels of an antibody, not an antigen.

The double-blind clinical studies of 3,315 individuals includes non-cancer controls and malignancies of the breast, lung, brain as well as melanomas, lymphomas, leukemias, and colorectal malignancies. Also, included were smaller number of malignancies of larynx, uterus, cervix, ovary, anus, stomach, esophagus, prostate, bladder, urethra, kidney, testis, thiroid, skin, fibrosarcoma, leimyosarcoma, osteogenic sarcoma, rhabdomysarcoma, mesothelioma, liposarcoma and mangioblastoma.

I personally took this test at the recommendation of my doctor at the Whitaker Wellness Center (www.whitakerwellness.com) two weeks ago and was pleased to find out that my serum levels of AMA were within the normal range. The test cost me $165 payable to ONCOLAB and the cost of drawing, processing and dry ice packed shipping to ONCOLAB (www.oncolabinc.com).